<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BRAINS: A Retrieval-Augmented System for Alzheimer's Detection and Monitoring - Health AI Hub</title>
    <meta name="description" content="BRAINS (Biomedical Retrieval-Augmented Intelligence for Neurodegeneration Screening) is a novel retrieval-augmented system designed for early and accurate Alzhe">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>BRAINS: A Retrieval-Augmented System for Alzheimer's Detection and Monitoring</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.02490v1" target="_blank">2511.02490v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-04
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Rajan Das Gupta, Md Kishor Morol, Nafiz Fahad, Md Tanzib Hosain, Sumaya Binte Zilani Choya, Md Jakir Hossen
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.02490v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.02490v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">BRAINS (Biomedical Retrieval-Augmented Intelligence for Neurodegeneration Screening) is a novel retrieval-augmented system designed for early and accurate Alzheimer's disease (AD) detection and monitoring, particularly in regions with limited diagnostic tools. It leverages Large Language Models (LLMs) within a dual-module architecture that combines cognitive diagnostics with case retrieval. The system demonstrates effectiveness in classifying disease severity and identifying early signs of cognitive decline using real-world datasets.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This system is highly relevant for medical practice as it offers a scalable and potentially explainable solution for early Alzheimer's disease diagnosis, which is critical for timely intervention and disease management, especially in areas lacking advanced diagnostic infrastructure.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper details an AI system (BRAINS) that leverages LLMs and retrieval-augmented methods for early and accurate detection and monitoring of Alzheimer's disease. This includes processing clinical data (cognitive scores, brain imaging metrics) to classify disease severity, predict risk, and identify cognitive decline. It serves as an AI-powered diagnostic and monitoring tool to assist clinicians in neurodegeneration screening, particularly emphasizing scalability and explainability in clinical settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical global challenge of early and accurate Alzheimer's disease detection, especially in underserved regions.</li>
                    
                    <li>Introduces BRAINS, a system utilizing the reasoning capabilities of Large Language Models (LLMs) for AD detection and monitoring.</li>
                    
                    <li>Features a dual-module architecture: a Cognitive Diagnostic Module and a Case Retrieval Module.</li>
                    
                    <li>The Diagnostic Module employs LLMs fine-tuned on cognitive (MMSE, CDR) and neuroimaging (brain volume) datasets for structured risk assessments.</li>
                    
                    <li>The Case Retrieval Module encodes patient profiles, retrieves similar historical cases, and integrates them via a Case Fusion Layer for enhanced contextual understanding.</li>
                    
                    <li>Evaluated on real-world datasets, demonstrating effectiveness in classifying disease severity and identifying early signs of cognitive decline.</li>
                    
                    <li>Positions BRAINS as a potential assistive tool for scalable, explainable, and early-stage AD detection with future application potential.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>BRAINS employs a dual-module architecture. The Cognitive Diagnostic Module utilizes Large Language Models (LLMs) fine-tuned on clinical datasets including MMSE and CDR scores, alongside neuroimaging data such as brain volume metrics, to perform structured assessments. The Case Retrieval Module encodes new patient profiles into latent representations, searches a curated knowledge base for similar historical cases, and then fuses these auxiliary cases with the input profile using a Case Fusion Layer. The resulting combined representation is subsequently processed with clinical prompts to generate inferences.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Evaluations on real-world datasets demonstrated BRAINS' effectiveness in accurately classifying Alzheimer's disease severity and successfully identifying early signs of cognitive decline, highlighting its potential as a diagnostic and monitoring tool.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>BRAINS has strong potential to serve as an assistive tool for clinicians, facilitating scalable, explainable, and early-stage Alzheimer's disease detection. Its capability to operate effectively in resource-limited regions could significantly broaden access to early diagnosis, leading to earlier therapeutic interventions and improved patient outcomes globally.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state specific limitations of the BRAINS system, its current development phase, or the scope of its evaluation.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The system offers hope for future applications within the field of neurodegeneration, implying potential for broader utility in long-term disease monitoring, personalized treatment stratification, or adaptation for other neurodegenerative conditions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Geriatrics</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                    <span class="tag">Public Health</span>
                    
                    <span class="tag">Cognitive Neuroscience</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Alzheimer's Disease</span>
                    
                    <span class="tag tag-keyword">Large Language Models</span>
                    
                    <span class="tag tag-keyword">Retrieval-Augmented Generation</span>
                    
                    <span class="tag tag-keyword">Cognitive Decline</span>
                    
                    <span class="tag tag-keyword">Neuroimaging</span>
                    
                    <span class="tag tag-keyword">Early Detection</span>
                    
                    <span class="tag tag-keyword">Disease Monitoring</span>
                    
                    <span class="tag tag-keyword">Artificial Intelligence in Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">As the global burden of Alzheimer's disease (AD) continues to grow, early and
accurate detection has become increasingly critical, especially in regions with
limited access to advanced diagnostic tools. We propose BRAINS (Biomedical
Retrieval-Augmented Intelligence for Neurodegeneration Screening) to address
this challenge. This novel system harnesses the powerful reasoning capabilities
of Large Language Models (LLMs) for Alzheimer's detection and monitoring.
BRAINS features a dual-module architecture: a cognitive diagnostic module and a
case-retrieval module. The Diagnostic Module utilizes LLMs fine-tuned on
cognitive and neuroimaging datasets -- including MMSE, CDR scores, and brain
volume metrics -- to perform structured assessments of Alzheimer's risk.
Meanwhile, the Case Retrieval Module encodes patient profiles into latent
representations and retrieves similar cases from a curated knowledge base.
These auxiliary cases are fused with the input profile via a Case Fusion Layer
to enhance contextual understanding. The combined representation is then
processed with clinical prompts for inference. Evaluations on real-world
datasets demonstrate BRAINS effectiveness in classifying disease severity and
identifying early signs of cognitive decline. This system not only shows strong
potential as an assistive tool for scalable, explainable, and early-stage
Alzheimer's disease detection, but also offers hope for future applications in
the field.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted for publication in ICMLA 2025</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>